Aldeyra Therapeutics, Inc.ALDXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-33.35T
↓ 900% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-3.33T
Historical baseline
PeriodValueYoY Change
2025$-33.35T-77173352.9%
2024$-43.21M-42.5%
2023$-30.33M+46.5%
2022$-56.64M-33.1%
2021$-42.56M-13.5%
2020$-37.49M+16.7%
2019$-44.98M-50.7%
2018$-29.86M-55.3%
2017$-19.22M-26.9%
2016$-15.15M-